Positive results from Phase II trial for Alzheimer’s

Positive results from Phase II trial for Alzheimer’s

Axon Neuroscience announces positive results from Phase II trial for a cure to Alzheimer’s Disease – Alzheimer’s Society comments.  On 9th September 2019, Axon Neuroscience has announced the results of the Phase II trial for AADvac1, its first-in-class vaccine aimed...
Moving more may reduce dementia risk

Moving more may reduce dementia risk

Moving more in old age may protect brain from dementia – Alzheimer’s Society comments.  A study by Rush University Medical Centre, published today in Neurology, suggests that older adults who move more than average – either in the...